| William R Beck, MD | |
|
700 Medical Center Dr, Suite 210, Newton, KS 67114-9013 | |
| (316) 804-4705 | |
| (316) 804-4710 |
| Full Name | William R Beck |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 41 Years |
| Location | 700 Medical Center Dr, Newton, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104894070 | NPI | - | NPPES |
| 100205540A | Medicaid | KS | |
| 0562380002 | Other | PTAN | |
| 021435 | Other | KS | MEDICARE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 0421695 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Newton Medical Center | Newton, KS | Hospital |
| Entity Name | Axtell Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346286036 PECOS PAC ID: 6406831544 Enrollment ID: O20040623001445 |
News Archive
A new study published in the journal bioRxiv in April 2020 reports the identification of a promising multidrug treatment against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for causing COVID-19 disease. The team predicts that this combination will prevent the virus from reproducing, hence both halting the transmission and progress of the disease.
Researchers from Mount Sinai School of Medicine have found that lactate, a type of energy fuel in the brain, plays a critical role in the formation of long-term memory. These findings have important implications for common illnesses like Alzheimer's disease, other neurodegenerative disorders, aging-related memory impairment and diabetes. The research is published in the March 4th issue of the journal Cell.
GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces the development of a new reliable and non-invasive diagnostic method, based on the measurement of a novel type of blood biomarker: small non-coding RNA, or miRNA.
A new study by researchers at the Karolinska University Hospital in Sweden shows that testing for the presence of SARS-CoV-2 nucleic acid can help in containing the virus spread. Detecting the presence of high amounts of SARS-CoV-2 nucleic acid predicts future symptomatic disease, they found.
› Verified 2 days ago
| Entity Name | Axtell Eye Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972975456 PECOS PAC ID: 3476857509 Enrollment ID: O20160209002845 |
News Archive
A new study published in the journal bioRxiv in April 2020 reports the identification of a promising multidrug treatment against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for causing COVID-19 disease. The team predicts that this combination will prevent the virus from reproducing, hence both halting the transmission and progress of the disease.
Researchers from Mount Sinai School of Medicine have found that lactate, a type of energy fuel in the brain, plays a critical role in the formation of long-term memory. These findings have important implications for common illnesses like Alzheimer's disease, other neurodegenerative disorders, aging-related memory impairment and diabetes. The research is published in the March 4th issue of the journal Cell.
GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces the development of a new reliable and non-invasive diagnostic method, based on the measurement of a novel type of blood biomarker: small non-coding RNA, or miRNA.
A new study by researchers at the Karolinska University Hospital in Sweden shows that testing for the presence of SARS-CoV-2 nucleic acid can help in containing the virus spread. Detecting the presence of high amounts of SARS-CoV-2 nucleic acid predicts future symptomatic disease, they found.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William R Beck, MD 700 Medical Center Dr, Suite 210, Newton, KS 67114-9017 Ph: (316) 283-2800 | William R Beck, MD 700 Medical Center Dr, Suite 210, Newton, KS 67114-9013 Ph: (316) 804-4705 |
News Archive
A new study published in the journal bioRxiv in April 2020 reports the identification of a promising multidrug treatment against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for causing COVID-19 disease. The team predicts that this combination will prevent the virus from reproducing, hence both halting the transmission and progress of the disease.
Researchers from Mount Sinai School of Medicine have found that lactate, a type of energy fuel in the brain, plays a critical role in the formation of long-term memory. These findings have important implications for common illnesses like Alzheimer's disease, other neurodegenerative disorders, aging-related memory impairment and diabetes. The research is published in the March 4th issue of the journal Cell.
GENFIT, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announces the development of a new reliable and non-invasive diagnostic method, based on the measurement of a novel type of blood biomarker: small non-coding RNA, or miRNA.
A new study by researchers at the Karolinska University Hospital in Sweden shows that testing for the presence of SARS-CoV-2 nucleic acid can help in containing the virus spread. Detecting the presence of high amounts of SARS-CoV-2 nucleic acid predicts future symptomatic disease, they found.
› Verified 2 days ago
Kevin P Allen, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 700 Medical Center Dr, Suite 110, Newton, KS 67114 Phone: 316-283-0113 Fax: 316-283-6401 |